-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Manufacturing is the foundation of a nation and the foundation of a strong country.
China is a big manufacturing country, and its overall scale and comprehensive strength are constantly improving, and it is gradually moving towards the goal of a strong manufacturing country
.
Recently, the Ministry of Industry and Information Technology stated at a press conference of the State Council Information Office that from 2012 to 2020, China's industrial added value will increase from 20.
9 trillion yuan to 31.
3 trillion yuan, of which the manufacturing industry's share of global added value will increase from 22.
5% to nearly 30%.
.
Investment in the manufacturing industry has increased significantly.
Since 2021, with the intensive release of favorable policies, investment in the domestic manufacturing industry has increased significantly
.
According to data released by the National Bureau of Statistics on September 15, manufacturing investment in January-August increased by 15.
7% year-on-year, with an average growth rate of 3.
3% over the two years
.
The industry pointed out that this is closely related to the recovery of the overall economy
.
On the one hand, since the beginning of this year, with the gradual expansion of market demand, the manufacturing industry has shown a scene of busy production, and corporate profits have continued to rise; on the other hand, favorable policies have continued to increase.
The rate of deduction for enterprise R&D expenses has been increased to 100%, and enterprises are allowed to enjoy the extra deduction policy for half a year, which is conducive to reducing enterprise costs, making confidence in the development of the industry more stable, and enhancing the investment motivation of manufacturing enterprises
.
The industry believes that the manufacturing industry will continue to maintain steady growth in the future.
It is expected that China's manufacturing investment will increase by about 12% year-on-year in 2021, with an average growth rate of about 5% in two years
.
Pharmaceutical machinery industry is actively embracing opportunities The pharmaceutical equipment industry is an important part of the manufacturing industry.
With policy support and investment overweight, the pharmaceutical machinery industry is actively embracing opportunities, continuously optimizing the industrial structure, and accelerating transformation and upgrading
.
From the perspective of national and local policies, intelligence, digitization, and greenization will be the new requirements for the high-quality development of the entire manufacturing industry, and the same is true in the pharmaceutical equipment industry
.
In June of this year, the Ministry of Industry and Information Technology and other six departments jointly issued the "Guiding Opinions on Accelerating the Cultivation and Development of High-Quality Manufacturing Enterprises", which provided guidance on improving the independent innovation capabilities of high-quality enterprises and guiding the development of high-end, intelligent, and green high-quality enterprises.
.
Among them, in terms of intelligence, opinions are put forward to accelerate the development of a new generation of information technology and the integration of manufacturing
.
In addition, according to the "Fourteenth Five-Year Plan for Intelligent Manufacturing Development" (draft for comments), by 2025, manufacturing enterprises above designated size will be basically digitized, and key industries in key industries will initially achieve intelligent transformation
.
Driven by policies, as well as the promotion of policies such as the consistency evaluation of generic drugs, the two-invoice system, and centralized procurement, the pharmaceutical machinery industry has accelerated its entry into a new stage of production capacity adjustment and intelligent upgrading, and gradually eliminated outdated production capacity
.
In recent years, with the advancement of new technologies such as 5G, artificial intelligence, big data, and blockchain, the digital transformation of the manufacturing industry has become a major trend
.
Especially since the beginning of this year, all localities have been seizing the opportunity to guide some traditional industries to actively embrace new technologies such as VR, Internet of Things, and big data, and implement technological transformation to digital transformation, thereby improving production efficiency and reducing production costs
.
It is reported that in the field of pharmaceutical equipment manufacturing, many companies are also actively involved in digital transformation
.
For example, companies are vigorously building "smart and smart pharmaceutical factories
.
" Among them, in terms of digitization, the company's hardware and software have taken care of it, and it has been able to realize real-time online automatic monitoring of drug manufacturing and circulation consumption; it can also automatically generate non-tamperable data, realize automatic read data, and store data in the cloud.
Avoid delays, dead ends and blind spots
.
In addition, in the context of "dual carbon", the pace of green development of the pharmaceutical equipment industry is also accelerating
.
As the pharmaceutical industry is a highly polluting industry, with the continuous pressure of environmental protection policies, pharmaceutical companies continue to improve the product and process requirements of pharmaceutical equipment.
Pharmaceutical companies need to increase research and development to create processes and processes that meet the green production and sustainable development of pharmaceutical companies.
Only equipment can meet the new demands of the market
.
The industry predicts that the demand for green investment and green technology transformation investment will increase throughout this year, and high-carbon emission industries will add a large number of clean energy equipment, energy-saving and environmental protection equipment and other technological transformation investment; green development-related new technology research and development investment will also accelerate
.
This is good news for pharmaceutical companies that are committed to green transformation, and will help boost their confidence in transformation and development.
.
It is worth mentioning that at present, most domestic pharmaceutical machinery manufacturers have insufficient understanding of the urgency and importance of digital, networked, and intelligent development, and the level of information technology application is still at the primary or partial application stage.
The industry believes that, The manufacturing industry, including the pharmaceutical equipment industry, needs to strengthen the construction of a new generation of information infrastructure in the future to further realize the digital and intelligent transformation
.
China is a big manufacturing country, and its overall scale and comprehensive strength are constantly improving, and it is gradually moving towards the goal of a strong manufacturing country
.
Recently, the Ministry of Industry and Information Technology stated at a press conference of the State Council Information Office that from 2012 to 2020, China's industrial added value will increase from 20.
9 trillion yuan to 31.
3 trillion yuan, of which the manufacturing industry's share of global added value will increase from 22.
5% to nearly 30%.
.
Investment in the manufacturing industry has increased significantly.
Since 2021, with the intensive release of favorable policies, investment in the domestic manufacturing industry has increased significantly
.
According to data released by the National Bureau of Statistics on September 15, manufacturing investment in January-August increased by 15.
7% year-on-year, with an average growth rate of 3.
3% over the two years
.
The industry pointed out that this is closely related to the recovery of the overall economy
.
On the one hand, since the beginning of this year, with the gradual expansion of market demand, the manufacturing industry has shown a scene of busy production, and corporate profits have continued to rise; on the other hand, favorable policies have continued to increase.
The rate of deduction for enterprise R&D expenses has been increased to 100%, and enterprises are allowed to enjoy the extra deduction policy for half a year, which is conducive to reducing enterprise costs, making confidence in the development of the industry more stable, and enhancing the investment motivation of manufacturing enterprises
.
The industry believes that the manufacturing industry will continue to maintain steady growth in the future.
It is expected that China's manufacturing investment will increase by about 12% year-on-year in 2021, with an average growth rate of about 5% in two years
.
Pharmaceutical machinery industry is actively embracing opportunities The pharmaceutical equipment industry is an important part of the manufacturing industry.
With policy support and investment overweight, the pharmaceutical machinery industry is actively embracing opportunities, continuously optimizing the industrial structure, and accelerating transformation and upgrading
.
From the perspective of national and local policies, intelligence, digitization, and greenization will be the new requirements for the high-quality development of the entire manufacturing industry, and the same is true in the pharmaceutical equipment industry
.
In June of this year, the Ministry of Industry and Information Technology and other six departments jointly issued the "Guiding Opinions on Accelerating the Cultivation and Development of High-Quality Manufacturing Enterprises", which provided guidance on improving the independent innovation capabilities of high-quality enterprises and guiding the development of high-end, intelligent, and green high-quality enterprises.
.
Among them, in terms of intelligence, opinions are put forward to accelerate the development of a new generation of information technology and the integration of manufacturing
.
In addition, according to the "Fourteenth Five-Year Plan for Intelligent Manufacturing Development" (draft for comments), by 2025, manufacturing enterprises above designated size will be basically digitized, and key industries in key industries will initially achieve intelligent transformation
.
Driven by policies, as well as the promotion of policies such as the consistency evaluation of generic drugs, the two-invoice system, and centralized procurement, the pharmaceutical machinery industry has accelerated its entry into a new stage of production capacity adjustment and intelligent upgrading, and gradually eliminated outdated production capacity
.
In recent years, with the advancement of new technologies such as 5G, artificial intelligence, big data, and blockchain, the digital transformation of the manufacturing industry has become a major trend
.
Especially since the beginning of this year, all localities have been seizing the opportunity to guide some traditional industries to actively embrace new technologies such as VR, Internet of Things, and big data, and implement technological transformation to digital transformation, thereby improving production efficiency and reducing production costs
.
It is reported that in the field of pharmaceutical equipment manufacturing, many companies are also actively involved in digital transformation
.
For example, companies are vigorously building "smart and smart pharmaceutical factories
.
" Among them, in terms of digitization, the company's hardware and software have taken care of it, and it has been able to realize real-time online automatic monitoring of drug manufacturing and circulation consumption; it can also automatically generate non-tamperable data, realize automatic read data, and store data in the cloud.
Avoid delays, dead ends and blind spots
.
In addition, in the context of "dual carbon", the pace of green development of the pharmaceutical equipment industry is also accelerating
.
As the pharmaceutical industry is a highly polluting industry, with the continuous pressure of environmental protection policies, pharmaceutical companies continue to improve the product and process requirements of pharmaceutical equipment.
Pharmaceutical companies need to increase research and development to create processes and processes that meet the green production and sustainable development of pharmaceutical companies.
Only equipment can meet the new demands of the market
.
The industry predicts that the demand for green investment and green technology transformation investment will increase throughout this year, and high-carbon emission industries will add a large number of clean energy equipment, energy-saving and environmental protection equipment and other technological transformation investment; green development-related new technology research and development investment will also accelerate
.
This is good news for pharmaceutical companies that are committed to green transformation, and will help boost their confidence in transformation and development.
.
It is worth mentioning that at present, most domestic pharmaceutical machinery manufacturers have insufficient understanding of the urgency and importance of digital, networked, and intelligent development, and the level of information technology application is still at the primary or partial application stage.
The industry believes that, The manufacturing industry, including the pharmaceutical equipment industry, needs to strengthen the construction of a new generation of information infrastructure in the future to further realize the digital and intelligent transformation
.